200 related articles for article (PubMed ID: 11837697)
21. Effects of progesterone and norethisterone on cephalexin transport and peptide transporter PEPT1 expression in human intestinal cell line Caco-2.
Watanabe K; Jinriki T; Sato J
Biol Pharm Bull; 2006 Jan; 29(1):90-5. PubMed ID: 16394517
[TBL] [Abstract][Full Text] [Related]
22. Transepithelial transport of 4-chloro-2-methylphenoxyacetic acid (MCPA) across human intestinal Caco-2 cell monolayers.
Kimura O; Tsukagoshi K; Hayasaka M; Endo T
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):530-6. PubMed ID: 22181038
[TBL] [Abstract][Full Text] [Related]
23. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells.
Balimane PV; Chong S; Patel K; Quan Y; Timoszyk J; Han YH; Wang B; Vig B; Faria TN
Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369
[TBL] [Abstract][Full Text] [Related]
24. Secretory transport of p-aminohippuric acid across intestinal epithelial cells in Caco-2 cells and isolated intestinal tissue.
Naruhashi K; Tamai I; Sai Y; Suzuki N; Tsuji A
J Pharm Pharmacol; 2001 Jan; 53(1):73-81. PubMed ID: 11206195
[TBL] [Abstract][Full Text] [Related]
25. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
[TBL] [Abstract][Full Text] [Related]
27. Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.
Jin X; Luong TL; Reese N; Gaona H; Collazo-Velez V; Vuong C; Potter B; Sousa JC; Olmeda R; Li Q; Xie L; Zhang J; Zhang P; Reichard G; Melendez V; Marcsisin SR; Pybus BS
J Pharmacol Toxicol Methods; 2014; 70(2):188-94. PubMed ID: 25150934
[TBL] [Abstract][Full Text] [Related]
28. Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent.
Berthelsen R; Nielsen CU; Brodin B
J Pharm Pharmacol; 2013 Jul; 65(7):970-9. PubMed ID: 23738724
[TBL] [Abstract][Full Text] [Related]
29. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
[TBL] [Abstract][Full Text] [Related]
30. Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Bhatnagar PK; Takata JS; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Aug; 13(8):1213-8. PubMed ID: 8865315
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexin.
Hu M; Zheng L; Chen J; Liu L; Zhu Y; Dantzig AH; Stratford RE
Pharm Res; 1995 Aug; 12(8):1120-5. PubMed ID: 7494822
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
33. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
Zheng Y; Benet LZ; Okochi H; Chen X
Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
[TBL] [Abstract][Full Text] [Related]
34. Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.
Oltra-Noguera D; Mangas-Sanjuan V; Centelles-Sangüesa A; Gonzalez-Garcia I; Sanchez-Castaño G; Gonzalez-Alvarez M; Casabo VG; Merino V; Gonzalez-Alvarez I; Bermejo M
J Pharmacol Toxicol Methods; 2015; 71():21-32. PubMed ID: 25433164
[TBL] [Abstract][Full Text] [Related]
35. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Omkvist DH; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs.
Yu L; Shen Q; Zhou Q; Jiang H; Bi H; Huang M; Zhou H; Zeng S
J Ethnopharmacol; 2013 Nov; 150(2):485-91. PubMed ID: 24036064
[TBL] [Abstract][Full Text] [Related]
37. Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):773-9. PubMed ID: 12134946
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
Tang F; Borchardt RT
Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
40. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.
Terada T; Sawada K; Saito H; Hashimoto Y; Inui K
Am J Physiol; 1999 Jun; 276(6):G1435-41. PubMed ID: 10362647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
